CV Sciences, Inc. (CVSI)
| Market Cap | 15.68M +100.2% |
| Revenue (ttm) | 14.37M -8.0% |
| Net Income | -1.48M |
| EPS | -0.01 |
| Shares Out | 184.26M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,796,063 |
| Average Volume | 1,629,986 |
| Open | 0.0680 |
| Previous Close | 0.0656 |
| Day's Range | 0.0654 - 0.0874 |
| 52-Week Range | 0.0230 - 0.0961 |
| Beta | 0.28 |
| RSI | 68.72 |
| Earnings Date | Mar 27, 2026 |
About CV Sciences
CV Sciences, Inc. develops, manufactures, markets, and sells herbal supplements, hemp-based cannabidiol (CBD), and plant based food products in North America. It offers its products under the PlusCBD, PlusHLTH, Cultured Foods, and Lunar Fox brand names in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, select distributors, brick and mortar retailers, and select e-tailers. The company was formerly known as CannaVest Corp. and changed its name to CV Sciences, Inc. in Jan... [Read more]
Full Company ProfileFinancial Performance
Financial StatementsNews
CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness
With 20g of clean protein, 5g of creatine, and LactoSpore® probiotics, Empowr supports everyday strength, mental energy and digestive balance without dairy or added sugar. Simple, functional nutrition...
CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD
SAN DIEGO, CA / ACCESS Newswire / December 22, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp ex...
CV Sciences, Inc. (CVSI) Q3 2025 Earnings Call Prepared Remarks Transcript
CV Sciences, Inc. (OTCQB:CVSI) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Company Participants Brendan Hawkins Joseph Dowling - CEO, Secretary & Director Joerg Grasser - Chief Financial Offic...
CV Sciences, Inc. Reports Third Quarter 2025 Financial Results
SAN DIEGO, CA / ACCESS Newswire / November 13, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp ex...
CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025
SAN DIEGO, CALIFORNIA / ACCESS Newswire / November 10, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in...
CV Sciences Launches Ignite: A Men's Performance Formula for Vitality, Recovery, Libido & Focus
Ignite delivers a powerful blend of proven botanicals along with our award-winning CBD, designed to help men stay strong, sharp, and ready-at work, in the gym, and beyond. SAN DIEGO, CALIFORNIA / ACCE...
CV Sciences, Inc. (CVSI) Q2 2025 Earnings Call Transcript
CV Sciences, Inc. (OTCQB:CVSI) Q2 2025 Earnings Conference Call August 13, 2025 4:30 PM ET Company Participants Brendan Hawkins - Corporate Participant Investor Relations - Corporate Participant Joerg...
CV Sciences, Inc. Reports Second Quarter 2025 Financial Results
SAN DIEGO, CA / ACCESS Newswire / August 13, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extr...
CV Sciences, Inc. To Announce Second Quarter 2025 Results On August 13, 2025
SAN DIEGO, CALIFORNIA / ACCESS Newswire / August 8, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in he...
CV Sciences, Inc. Applauds Governor Abbot's Veto of Senate Bill 3
SAN DIEGO, CALIFORNIA / ACCESS Newswire / June 23, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hem...
CV Sciences, Inc. (CVSI) Q1 2025 Earnings Call Transcript
CV Sciences, Inc. (OTCQB:CVSI) Q1 2025 - Earnings Conference Call May 14, 2025 4:00 PM ET Company Participants Brendan Hawkins - IR Joseph Dowling - CEO Joerg Grasser - CFO Conference Call Participant...
CV Sciences, Inc. Reports First Quarter 2025 Financial Results
SAN DIEGO, CA / ACCESS Newswire / May 14, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extract...
CV Sciences, Inc. to Announce First Quarter 2025 Results on May 14, 2025
SAN DIEGO, CA / ACCESS Newswire / May 9, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts...
CV Sciences, Inc. (CVSI) Q4 2024 Earnings Call Transcript
CV Sciences, Inc. (OTCQB:CVSI) Q4 2024 Earnings Conference Call March 27, 2025 10:00 AM ET Company Participants Brendan Hawkins - Investor Relations Joseph Dowling - Chief Executive Officer Joerg Gras...
CV Sciences, Inc. Reports Fiscal Year-End 2024 Financial Results
SAN DIEGO, CA / ACCESS Newswire / March 27, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extra...
CV Sciences Unveils Lunar Fox Food Co., an All-New Line of Plant-Based Foods
The innovative product line offers a unique choice of plant-based, 100% natural alternatives to the foods everyone loves. SAN DIEGO, CA / ACCESS Newswire / March 26, 2025 / CV Sciences, Inc. (OTCQB:CV...
CV Sciences, Inc. To Announce Year End and Fourth Quarter 2024 Results On March 27, 2025
SAN DIEGO, CALIFORNIA / ACCESS Newswire / March 20, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in he...
CV Sciences Unveils New Aura Collection THC Fizz Tablets
The innovative, lemon-flavored fast-acting tablets provide a quick, uplifting experience, perfect for enhancing social moments or relaxing at home. SAN DIEGO, CA / ACCESS Newswire / February 5, 2025 /...
CV Sciences, Inc. Enters Into Definitive Agreement to Acquire Extract Labs
SAN DIEGO , Nov. 21, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o...
CV Sciences, Inc. (CVSI) Q3 2024 Earnings Call Transcript
CV Sciences, Inc. (OTCQB:CVSI) Q3 2024 Earnings Conference Call November 14, 2024 10:00 AM ET Company Participants Brendan Hawkins - Investor Relations Joseph Dowling - Chief Executive Officer Joerg G...
CV Sciences, Inc. Reports Third Quarter 2024 Financial Results
SAN DIEGO , Nov. 14, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o...
CV Sciences, Inc. To Announce Third Quarter 2024 Results On November 14, 2024
SAN DIEGO , Nov. 8, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o...
CV Sciences Launches +PlusHLTH, a New Line of Cannabinoid-Free Supplements
Designed to elevate focus, mood, energy, and metabolism with clinically proven wellness ingredients Available in three variations - Clarity, Peace, and ReShape SAN DIEGO , Aug. 27, 2024 /PRNewswire/ -...
CV Sciences, Inc. (CVSI) Q2 2024 Earnings Call Transcript
CV Sciences, Inc. (CVSI) Q2 2024 Earnings Call Transcript
CV Sciences, Inc. Reports Second Quarter 2024 Financial Results
SAN DIEGO , Aug. 13, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o...